Inverna Therapeutics will be presenting at BIO-Europe Spring 2026

Press release

Odense, Denmark – March 06, 2026 – Inverna Therapeutics is pleased to announce its participation in the Life Science Spring Innovation Week 2026, featuring BIO-Europe Spring 2026, held March 23 – 25, 2026, and the directly following LSX World Congress Europe 2026, March 25 – 26, 2026.

“Our recent advancements position Inverna to actively pursue strategic partnerships and fundraising opportunities.”
said Poul Sørensen, CEO of Inverna Therapeutics. “We look forward to connecting with partners and investors to share our scientific progress, vision and growth strategy.”

Inverna’s CEO Poul Sørensen welcomes meeting requests through the respective partnering platforms.

About Inverna Therapeutics
Inverna Therapeutics is a Danish biotech company, founded in 2024 emerging from Southern Danish University in Odense, nurtured by Argobio Studio, a launch platform for Europe’s best medicinal science. With our proprietary drug discovery platform, we’re dedicated to developing transformative RNA therapeutics based on precision RNA splicing modulation. Our unique technology allows us to design, test, and develop highly specific activators of pseudo-exons in disease-relevant target RNA. Today, we are pursuing breakthroughs in neurological disorders such as Parkinson’s disease, somatic repeat expansion diseases, and Huntington’s disease, knowing that the approach can extend to other organ systems and diseases.

Contact :